Tempus expands collaboration with AstraZeneca to support guideline-directed biomarker testing in NSCLC
Tempus, a leader in Artificial Intelligence and precision medicine, has announced an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm physicians with technology that supports the delivery of guideline-directed biomarker...